{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:27:02Z","timestamp":1791192422499,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.siny.2004.10.004","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T23:04:19Z","timestamp":1105139059000},"page":"185-194","source":"Crossref","is-referenced-by-count":87,"title":["New dosing strategies for antibacterial agents in the neonate"],"prefix":"10.1016","volume":"10","author":[{"given":"Matthijs","family":"de Hoog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2004.10.004_bib1","series-title":"Infectious Diseases of the Fetus & Newborn Infant","first-page":"836","article-title":"Bacterial sepsis and meningitis","author":"Klein","year":"1995"},{"key":"10.1016\/j.siny.2004.10.004_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-3476(96)70192-0","article-title":"Early onset sepsis in very low birth weight neonates: a report from the national institute of child health and human development neonatal research network","volume":"129","author":"Stoll","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00006454-199907000-00005","article-title":"Increasing incidence of gram-negative rod bacteremia in a newborn intensive care unit","volume":"18","author":"Shah","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.siny.2004.10.004_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(96)70191-9","article-title":"Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network","volume":"129","author":"Stoll","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003495-199958030-00003","article-title":"Antibiotics in neonatal infections: a review","volume":"58","author":"Fanos","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.siny.2004.10.004_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0924-8579(02)00027-4","article-title":"Developments in PK\/PD: optimising efficacy and prevention of resistance. A critical review of PK\/PD in in vitro models","volume":"19","author":"MacGowan","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.siny.2004.10.004_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00008480-200204000-00006","article-title":"Renal aspects of the term and preterm infant: a selective update","volume":"14","author":"Drukker","year":"2002","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib8","first-page":"439","article-title":"Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin","volume":"40","author":"van den Anker","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2004.10.004_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00003088-200443070-00001","article-title":"Vancomycin: pharmacokinetics and administration regimens in neonates","volume":"43","author":"de Hoog","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.siny.2004.10.004_bib10","series-title":"Introduction to Paediatric and Perinatal Drug Therapy","first-page":"117","article-title":"The use of aminoglycosides in newborn infants","author":"de Hoog","year":"2003"},{"key":"10.1016\/j.siny.2004.10.004_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/infdis\/129.4.461","article-title":"Pharmacokinetics of ampicillin in the newborn infant","volume":"129","author":"Yoshioka","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.siny.2004.10.004_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejcts.2003.11.017","article-title":"Pharmacokinetics of intravenous flucloxacillin and amoxicillin in neonatal and infant cardiopulmonary bypass surgery","volume":"25","author":"Adrianzen Vargas","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.siny.2004.10.004_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1128\/AAC.39.2.431","article-title":"Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks","volume":"39","author":"Huisman-de Boer","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00446070","article-title":"Serum levels of ampicillin and gentamycin in neonates of varying gestational age","volume":"145","author":"Dahl","year":"1986","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1021\/js970068l","article-title":"Population pharmacokinetics of intravenous amoxicillin in very low birth weight infants","volume":"86","author":"Charles","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.siny.2004.10.004_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00558169","article-title":"Flucloxacillin kinetics in newborn infants","volume":"36","author":"Herngren","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.siny.2004.10.004_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1651-2227.1991.tb11752.x","article-title":"Ampicillin-aminoglycoside combinations as initial treatment for neonatal septicaemia or meningitis. A retrospective evaluation of 12 years' experience","volume":"80","author":"Tessin","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.siny.2004.10.004_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00543977","article-title":"Pharmacokinetics of free and total flucloxacillin in newborn infants","volume":"32","author":"Herngren","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.siny.2004.10.004_bib19","series-title":"Neofax: A Manual for Drugs used in Neonatal Care","author":"Young","year":"2003"},{"key":"10.1016\/j.siny.2004.10.004_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3476(89)80573-6","article-title":"Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates","volume":"114","author":"Kearns","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-3476(84)80032-3","article-title":"Pharmacokinetics of ceftriaxone in neonates and infants with meningitis","volume":"105","author":"Martin","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0732-8893(89)90051-5","article-title":"Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn","volume":"12","author":"Aujard","year":"1989","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.siny.2004.10.004_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-3476(82)80466-6","article-title":"Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics","volume":"100","author":"Kafetzis","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0009-9236(95)90021-7","article-title":"Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age","volume":"58","author":"van den Anker","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2004.10.004_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2165\/00003088-199222040-00004","article-title":"Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval","volume":"22","author":"Kearns","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.siny.2004.10.004_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000014208","article-title":"Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin","volume":"77","author":"Dellagrammaticas","year":"2000","journal-title":"Biol Neonate"},{"key":"10.1016\/j.siny.2004.10.004_bib27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/BF01954122","article-title":"A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases\u2013Neonatal Sepsis Study Group","volume":"151","author":"de Louvois","year":"1992","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib28","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1128\/AAC.39.9.2048","article-title":"Once-daily versus twice-daily administration of ceftazidime in the preterm infant","volume":"39","author":"van den Anker","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00496420","article-title":"Comparison of serum concentrations of ceftazidime and tobramycin in newborn infants","volume":"147","author":"Tessin","year":"1988","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib30","first-page":"873","article-title":"Ceftriaxone effect on bilirubin-albumin binding","volume":"80","author":"Fink","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2004.10.004_bib31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1542\/peds.112.5.1095","article-title":"Streptococcus pneumoniae infections in the neonate","volume":"112","author":"Hoffman","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2004.10.004_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2165\/00003088-199019040-00003","article-title":"Clinical pharmacokinetics of antibacterial drugs in neonates","volume":"19","author":"Paap","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.siny.2004.10.004_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000457657","article-title":"Early neonatal drug utilization in preterm newborns in neonatal intensive care units. Italian Collaborative Group on Preterm Delivery","volume":"11","year":"1988","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.siny.2004.10.004_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mcp.2002.123595","article-title":"Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring","volume":"71","author":"de Hoog","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2004.10.004_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mpd.2003.mpd037","article-title":"Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss","volume":"142","author":"de Hoog","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1542\/peds.104.4.900","article-title":"Neonatal screening for hearing disorders in infants at risk: incidence, risk factors, and follow-up","volume":"104","author":"Meyer","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2004.10.004_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.siny.2004.10.004_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00007691-199302000-00009","article-title":"Determination of a gentamicin loading dose in neonates and infants","volume":"15","author":"Semchuk","year":"1993","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.siny.2004.10.004_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once-daily aminoglycoside program administered to 2,184 adult patients","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib40","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1128\/AAC.40.11.2494","article-title":"Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy","volume":"40","author":"Prins","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0009-9236(97)90117-X","article-title":"Tobramycin population pharmacokinetics in neonates","volume":"62","author":"de Hoog","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2004.10.004_bib42","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1542\/peds.103.6.1228","article-title":"Once-daily gentamicin dosing in newborn infants","volume":"103","author":"Lundergan","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2004.10.004_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1440-1754.1999.00352.x","article-title":"Once versus twice daily amikacin in neonates: prospective study on toxicity","volume":"35","author":"Kotze","year":"1999","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.siny.2004.10.004_bib44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1651-2227.1997.tb08926.x","article-title":"Increase of staphylococci in neonatal septicaemia: a fourteen-year study","volume":"86","author":"Kallman","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib45","first-page":"2","article-title":"Vancomycin for prophylaxis against sepsis in preterm neonates","author":"Craft","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2004.10.004_bib46","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1542\/peds.103.4.e48","article-title":"Lack of vancomycin-associated nephrotoxicity in newborn infants: a case- control study","volume":"103","author":"Bhatt-Mehta","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2004.10.004_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000013987","article-title":"Use of teicoplanin in preterm neonates with staphylococcal late-onset neonatal sepsis","volume":"73","author":"Degraeuwe","year":"1998","journal-title":"Biol Neonate"},{"key":"10.1016\/j.siny.2004.10.004_bib48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jac\/39.6.789","article-title":"The pharmacokinetics of teicoplanin in infants and children","volume":"39","author":"Reed","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2125.1999.00850.x","article-title":"The therapeutic monitoring of antimicrobial agents","volume":"47","author":"Begg","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2004.10.004_bib50","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/AAC.43.8.1932","article-title":"Bactericidal activity of vancomycin in cerebrospinal fluid","volume":"43","author":"Nagl","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib51","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1093\/clinids\/3.Supplement.S282","article-title":"Pharmacology and efficacy of vancomycin for staphylococcal infections in children","volume":"3","author":"Schaad","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.siny.2004.10.004_bib52","first-page":"107","article-title":"Vancomycin pharmacokinetics in small, seriously ill infants","volume":"140","author":"Naqvi","year":"1986","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.siny.2004.10.004_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2125.1998.00763.x","article-title":"Constant rate infusion of vancomycin in premature neonates: a new dosage schedule","volume":"46","author":"Pawlotsky","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2004.10.004_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00003088-200039030-00001","article-title":"Clinical pharmacokinetics of teicoplanin","volume":"39","author":"Wilson","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.siny.2004.10.004_bib55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s004310050629","article-title":"A review of teicoplanin in the treatment of serious neonatal infections","volume":"156","author":"Fanos","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.siny.2004.10.004_bib56","first-page":"646","article-title":"Why monitor peak vancomycin concentrations? (letter)","volume":"345","author":"de Hoog","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.siny.2004.10.004_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jac\/41.1.141","article-title":"Trough-only monitoring of serum vancomycin concentrations in neonates","volume":"41","author":"Shackley","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib58","doi-asserted-by":"crossref","first-page":"F221","DOI":"10.1136\/fn.81.3.F221","article-title":"Pharmacokinetics and dose requirements of vancomycin in neonates","volume":"81","author":"Grimsley","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2004.10.004_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00007691-199508000-00001","article-title":"Vancomycin pharmacokinetics and dosing in premature neonates","volume":"17","author":"McDougal","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.siny.2004.10.004_bib60","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0310057X9502300603","article-title":"Changes in vancomycin pharmacokinetics in critically ill infants","volume":"23","author":"Gous","year":"1995","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.siny.2004.10.004_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00007691-199506000-00005","article-title":"Bayesian forecasting of serum vancomycin concentrations in neonates and infants","volume":"17","author":"Rodvold","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.siny.2004.10.004_bib62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0009-9236(03)00226-1","article-title":"Impact of ontogeny on linezolid disposition in neonates and infants","volume":"74","author":"Kearns","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2004.10.004_bib63","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1097\/01.inf.0000086954.43010.63","article-title":"Linezolid pharmacokinetics in pediatric patients: an overview","volume":"22","author":"Jungbluth","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.siny.2004.10.004_bib64","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.siny.2004.10.004_bib65","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/AAC.47.11.3554-3560.2003","article-title":"Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases","volume":"47","author":"Paterson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00003088-200039030-00002","article-title":"Comparative pharmacokinetics of the carbapenems: clinical implications","volume":"39","author":"Mouton","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.siny.2004.10.004_bib67","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/AAC.34.6.1172","article-title":"Clinical pharmacology of imipenem and cilastatin in premature infants during the first week of life","volume":"34","author":"Reed","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib68","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00007691-200106000-00003","article-title":"Pharmacokinetics of meropenem in preterm neonates","volume":"23","author":"van Enk","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.siny.2004.10.004_bib69","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0891-5520(05)70102-1","article-title":"Bacterial meningitis and the newborn infant","volume":"13","author":"Pong","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.siny.2004.10.004_bib70","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/515003","article-title":"Antibiotic pharmacodynamics in cerebrospinal fluid","volume":"27","author":"Lutsar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.siny.2004.10.004_bib71","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF01650725","article-title":"Cefotaxime pharmacokinetics and treatment of meningitis in neonates","volume":"17","author":"Jacobs","year":"1989","journal-title":"Infection"},{"key":"10.1016\/j.siny.2004.10.004_bib72","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0891-5520(05)70096-9","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in meningitis","volume":"13","author":"Andes","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.siny.2004.10.004_bib73","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1128\/AAC.42.8.2012","article-title":"Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy","volume":"42","author":"Nau","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.siny.2004.10.004_bib74","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00006454-200210000-00010","article-title":"Clinical implications of inducible beta-lactamase activity in Gram-negative bacteremia in children","volume":"21","author":"Boyle","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.siny.2004.10.004_bib75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/adc.87.3.207","article-title":"The emergence of resistant pneumococcal meningitis\u2013implications for empiric therapy","volume":"87","author":"McMaster","year":"2002","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.siny.2004.10.004_bib76","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1084-2756(03)00123-4","article-title":"Treatment and prevention of necrotizing enterocolitis","volume":"8","author":"Lee","year":"2003","journal-title":"Semin Neonatol"},{"key":"10.1016\/j.siny.2004.10.004_bib77","series-title":"Textbook of Neonatology","first-page":"744","article-title":"Gastrointestinal disorders","author":"Newel","year":"1999"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X04000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X04000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T07:39:59Z","timestamp":1586072399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X04000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1744165X04000721"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2004.10.004","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}